Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$5.31 - $10.98 $5 - $10
-1 Reduced 0.02%
6,060 $32,000
Q1 2023

May 08, 2023

SELL
$10.23 - $17.14 $9,871 - $16,540
-965 Reduced 13.73%
6,061 $66,000
Q4 2022

Feb 01, 2023

BUY
$13.96 - $20.4 $15,830 - $23,133
1,134 Added 19.25%
7,026 $103,000
Q3 2022

Nov 09, 2022

BUY
$17.85 - $26.95 $80,860 - $122,083
4,530 Added 332.6%
5,892 $113,000
Q2 2022

Aug 09, 2022

SELL
$16.33 - $22.2 $2,155 - $2,930
-132 Reduced 8.84%
1,362 $29,000
Q1 2022

Apr 21, 2022

BUY
$14.38 - $22.79 $21,483 - $34,048
1,494 New
1,494 $29,000

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.